Company ProfilePremium

Hyfusin Group Holdings Limited

Company Profile Analysis

Ticker: 8512.HK凱富善集團控股有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Hyfusin Group Holdings Limited - Company showcase

Year Founded & Workforce

1993

1,240 Employees

Hyfusin Group Holdings Limited logo

Hyfusin Group Holdings Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Hyfusin Group Holdings Limited Overview

Hyfusin is a Hong Kong-headquartered, Vietnam-based contract manufacturer of candles and home-fragrance products, selling almost exclusively to department-store operators and buying agents headquartered in the United States and United Kingdom. It manufactures largely to customer specification — essentially private-label/OEM supply with design-support, sampling, laboratory testing and material-procurement services layered on top. Scented candles account for roughly 71–74% of revenue, and the US for 87–93%. The business is small (FY2025 revenue HK$898.1M, ≈US$115M) and highly concentrated: one customer contributed 45% of FY2025 sales and as much as 63% in FY2023. Its competitive position rests on a low-cost, increasingly automated Vietnamese production base (three factories, two built since 2021), long customer relationships and a very conservative balance sheet (net cash ≈HK$393M at FY2025 versus a market capitalisation of ≈HK$344M). Its key vulnerabilities are customer concentration, US tariff exposure, price pressure and, since 2025, deteriorating margins and receivable quality.


Company's own description (paraphrased from FY2025 and FY2024 results announcements)

The FY2025 results announcement describes the group as a leading manufacturer and distributor of high-quality candles — scented, decorative and daily-use — together with home-fragrance items such as diffusers, headquartered in Hong Kong with core manufacturing primarily in Vietnam [S1]. It states that its primary focus is the mid-to-high-end segment in the US and UK, serving major department-store operators and professional buying agents, and that it mainly manufactures to customers' requirements and specifications [S1]. Value-added services listed include product design, material procurement, pre-production sampling, laboratory testing and quality-improvement recommendations [S1][S2]. Revenue disaggregation notes confirm that the group's market comprises department stores and buying agents headquartered in the US and UK, that contracts are short-term with fixed prices, and that all revenue is recognised at a point in time when goods ship to the customer-specified location [S1].

Business model and revenue model

DimensionCharacterisationEvidence
Revenue type100% product sales; no service, subscription or licensing revenue reportedAll revenue "sale of candle products", recognised at a point in time [S1]
Contract structureShort-term purchase orders, fixed prices agreed per order; performance obligations ≤1 year[S1]
Customer typesUS/UK department-store operators and buying agents (i.e., retailers' sourcing arms)[S1][S2]
Manufacturing modelBuild-to-specification (OEM/private label) with ODM-like design input[S2][S3]
Sales channelDirect B2B sales plus incentive-based third-party sales representatives in the US (since 2018)[S1][S4]
Production footprintVietnam (Dong Nai Province) factories; Hong Kong HQ; Singapore subsidiary; small US non-current asset base from FY2025[S1]
Functional currency / pricingUSD functional currency; sales effectively USD-priced; costs partly in VND and HKD[S1]
Credit terms30–180 days to trade customers (FY2025); 30–120 days in FY2021[S1][S4]

Value-chain position

Hyfusin sits in the middle of the home-fragrance value chain: it buys wax, fragrance oils, wicks, glass vessels and packaging; formulates, pours and finishes candles in Vietnam; and ships to retailers who own the consumer brand, merchandising and pricing. It does not appear to own consumer brands or operate retail channels (no brand revenue is disclosed in filings reviewed). Its economic leverage therefore derives from manufacturing cost, quality, speed of sampling/design iteration and compliance capability (e.g., laboratory testing), not from brand equity.

End-markets

End-marketExposureEvidence
US home décor / home fragrance retail (department stores, mass/discount retailers via buying agents)86.6% of FY2025 revenue; 93.1% of 1H2026 revenue[S1][S5]
UK home décor / home fragrance retail12.2% of FY2025 revenue; 6.8% of 1H2026[S1][S5]
Other markets1.2% of FY2025 revenue[S1]

Independent characterisation

Hyfusin is best understood as a single-segment, export-oriented private-label candle factory whose fortunes are tied to the purchasing cycles of a handful of large US retailers. The business enjoyed an exceptional 2020–2024 period (revenue +64% from FY2020 to FY2024; gross margin peaking at 38.7% in FY2023–24) as US home-fragrance demand rose during and after the pandemic and wax costs normalised. From FY2025 the cycle has turned: average selling prices fell, production costs rose, the largest customer's purchases dropped 19%, receivable impairments climbed sharply, and 1H2026 net profit fell 56.6% year on year [S1][S5]. Against that, the group's balance sheet is unusually strong for its size: at 31 Dec 2025 cash of HK$405.6M exceeded total liabilities (HK$112.7M) by more than three times [S1]. The equity story is therefore one of a cash-rich, tightly controlled family company trading at a discount to its net cash, with operating momentum currently negative.

Strategy

Stated strategy (themes from the latest annual results)

The FY2025 announcement's outlook frames the environment as challenging and commits to three levers: proactive marketing, more resources for product development, and reinforced cost control [S1]. Management also describes the aim of being "the competitive manufacturer among the industry" [S1]. Operational themes repeated across FY2023–FY2025 are: (i) capacity and automation in Vietnam (two highly automated factories from 2022 and 2024 plus renovation of the original facility); (ii) incentive-based US sales representatives to win new business; (iii) liquidity improvement by reducing external borrowings during the high-rate period; and (iv) leveraging long-standing customer relationships and a "diversified production strategy" to navigate external uncertainty, especially US tariff policy [S1][S2][S3]. No investor day has been held or transcript published.

Initiatives announced in the last 24 months (Oct 2024 – Oct 2026)

InitiativeDateDetailTargets / spendSource
Renovation of original production facilityOct 2024 – Dec 2025Contract VND32.68bn (≈HK$10.1M); ≈VND31.4bn (≈HK$9.8M) paid; completed by 31 Dec 2025Efficiency improvement; no quantified target[S1]
Third factory commissioning2,024Plot 56 factory and warehouseCapacity expansion; no capacity figures disclosed[S2]
Automation capex1H2026HK$23.07M PPE investment, mainly automation in VietnamNot quantified[S5]
US sales representativesOngoing; reiterated FY2025Incentive-based contracts to capture new US businessNot quantified[S1]
Debt reductionFY2024–FY2025Bank borrowings cut from HK$15.0M to HK$8.3MGearing 1.6% at FY2025[S1]
Share option schemeAdopted 7 Jun 2024Employee incentive tool; unused to 30 Jun 2026—[S2][S5]
Tariff monitoring/mitigationFY2025Management states it has implemented strategic initiatives to protect US competitiveness (not specified)Not specified[S1]

Sustainability/ESG commitments: not identified in sources reviewed. Cost programmes with targets: none quantified. Medium-term financial targets / guidance: none provided; the company issues profit alerts/warnings under GEM Rule 17.10 rather than formal guidance [S6][S19].

Analyst view of strategy

The strategy is operational rather than transformational: more automated capacity in Vietnam, cost control and sales-rep-led customer acquisition. There is no disclosed plan for own-brand development, e-commerce, geographic diversification beyond the US/UK, or capital return — despite the balance sheet strongly supporting the latter. With capacity now expanded and demand softening, utilisation (undisclosed) is the key unknown for margins.

Products & Services

The group does not publish a product catalogue, SKU count, brand list or pricing in its statutory filings; the products are largely made to customer specification and sold under retailers' own brands. The catalogue below is therefore assembled from category disclosures, the recall announcement and third-party profiles; anything beyond these is marked not publicly disclosed.

Sources: [S1][S5][S9][S12].

Value-added services (bundled, not separately priced): product design and design suggestions on customer specifications; raw-material selection and procurement; provision of sample candles before mass production; laboratory testing; and recommendations for quality improvement [S1][S2]. These are not separately invoiced — no service revenue is reported — but they underpin customer stickiness. The group's major customer recognised it with a "Business Partner Award Winner for Differentiate Owned Brands" in 2020 and 2021 for helping develop that customer's candle category [S4].

Launch/version years: not publicly disclosed for any product.

Product Portfolio

Product lineDescription (from filings)Key specs / capabilitiesTarget customerLatest disclosed revenuePricing modelNamed flagship offerings

Scented candles

Candles with fragrance and colour additives; group's best-selling category every year FY2020–FY2025

Formats include glass-jar candles (confirmed by the Dec 2023 recall of ≈7.1M glass-jar units); other vessel types not disclosed

US/UK department stores and buying agents, mid-to-high-end segment

HK$639.2M (FY2025, 71.2%); HK$252.2M (1H2026, 73.8%)

Fixed per-order prices; short-term contracts

Not publicly disclosed (private label)

Daily-use candles

Functional/unscented-type everyday candles (precise formats not specified)

—

Same

HK$112.3M (FY2025, 12.5%)

Same

—

Decorative candles

Candles sold primarily for decorative/seasonal display

—

Same

HK$50.2M (FY2025, 5.6%)

Same

—

Others, incl. diffusers

Home-fragrance products, principally reed/fragrance diffusers

Not publicly disclosed; third-party profile of Fleming International (HK) also lists poly-resin photo frames, bath products and candle holders as historical lines (not confirmed in current filings)

Same

HK$96.4M (FY2025, 10.7%)

Same

—

“—” = not publicly disclosed.

Financial Narrative

All figures HKD M, fiscal years ended 31 December, audited, per results announcements [S1][S2][S3][S4] unless labelled. FY2020 included for context where useful.

Income statement

Non-recurring items: FY2023 includes a HK$53.0M recall provision in selling expenses; FY2024 includes a HK$29.7M reversal of that provision in other gains; FY2025 includes a HK$15.3M trade-receivable impairment [S1][S2][S3]. Management's adjusted net profit: FY2023 HK$155.3M ex-provision; FY2024 HK$141.7M ex-reversal [S3][S2].

Computed from filed figures. Revenue CAGR FY2021–FY2025 (4 years): 2.5%; FY2020–FY2025 (5 years): 10.1% (computed).

Commentary — income statement. Three distinct phases are visible. (1) Pandemic boom, FY2020–21: revenue jumped 46.6% in FY2021 on scented (+HK$230.2M) and daily-use (+HK$48.3M) demand, but gross margin fell from 37.2% to 33.1% because average wax cost rose ≈37% [S4]. (2) Destocking and recovery, FY2022–24: FY2022 revenue fell 16% amid US retailer destocking and gross margin bottomed at 30.3%; FY2023 delivered record revenue and a 38.7% gross margin on lower raw-material prices and overhead absorption from the automated second factory [S3]. FY2024 added another 5% of revenue at a constant 38.7% margin [S2]. (3) Margin compression, FY2025–1H2026: gross margin collapsed to 31.6% in FY2025 on lower selling prices and higher production costs [S1], and to 28.6% in 1H2026 [S5]. The FY2025 decline in administrative expenses (−22%, mostly HK$31.5M lower salaries/bonuses) cushioned operating profit [S1], but this is a cyclical bonus effect rather than structural efficiency. Finance costs remain high relative to tiny gross debt because the group carries VND loans at 5.7–8.0% and historically used supplier-finance facilities [S1].

Half-year trend

1H2026 per [S5]; 1H2025 values per [S5] where stated, otherwise derived from stated percentage changes (1H2025 gross profit derived from −14.16%; admin from −12.82%; S&D from −1.4%; other income from −46.5%; finance costs from −25.08%) — derived items are approximations. 1H2026 included a HK$13.43M trade-receivable impairment [S5].

Balance sheet

Sources: [S4] FY2021; [S3] FY2022–23; [S2] FY2024; [S1] FY2025. Goodwill/intangibles: none reported on the face of the balance sheet. The FY2022 land-use right acquisition (≈HK$31.9M) is classified within right-of-use assets.

At 30 Jun 2026 [S5]: net assets HK$768.04M; total liabilities HK$195.02M (so total assets ≈HK$963.1M, computed); bank borrowings HK$30.85M; gearing 4.7%. Cash balance at 30 Jun 2026 not available in the summaries reviewed.

Commentary — balance sheet. Equity has more than doubled since FY2021 (HK$330M → HK$748M) through retained earnings, with no dividends paid. Gross bank debt fell from HK$62.6M to HK$8.3M, and the company-defined gearing ratio (total debt incl. leases ÷ equity) dropped from 20.0% to 1.6% [S1][S4]. The asset base has shifted toward fixed assets (PPE up from HK$60.7M to HK$172.4M) as the group built two factories and renovated a third. The principal balance-sheet warning sign is receivable quality: gross trade receivables doubled in FY2024 (HK$65.7M → HK$133.4M) and the credit-loss allowance jumped from HK$2.4M to HK$17.7M in FY2025; receivables more than 180 days old by invoice date rose from HK$1.0M to HK$13.0M [S1][S2]. Another HK$13.4M impairment was booked in 1H2026 [S5]. Credit terms have also lengthened from 30–120 days (FY2021) to 30–180 days [S4][S1].

Cash flow

Source: [S10] (S&P Global Market Intelligence data). The preliminary results announcements reviewed do not reproduce the cash flow statement; cross-check: PPE additions per filings were HK$67.2M (FY2024) and HK$53.9M (FY2025) [S1], consistent in magnitude with aggregator capex once deposits paid are considered. Buyback amount (HK$30.0M) agrees with [S7].

Commentary — cash flow. FY2023 operating cash flow (HK$307M) was flattered by HK$154M of working-capital release, including a large rise in payables/accruals and the non-cash HK$53M recall provision. FY2024 reversed part of this (receivables +HK$70.9M). FY2025 operating cash flow of HK$202M benefited from inventory reduction (−HK$25.4M) and receivable collection. Cumulative FY2021–FY2025 free cash flow was ≈HK$558M (computed), of which only HK$30M was returned to shareholders (the 2024 buyback); the remainder accumulated as cash or repaid debt.

Ratios

All computed from filed figures (year-end balances for DIO/DSO/DPO; average balances for ROE/ROA; ROIC uses core operating profit × (1 − effective tax rate) over year-end equity + total debt − cash). Debt-to-equity matches the company's reported gearing ratio in every year [S1][S2][S3][S4]. Aggregator ROE for FY2025 TTM is cited as 18.23% by Wisesheets, which uses a different denominator — discrepancy noted.

Commentary — ratios. Returns are high for a manufacturer because the capital base excluding cash is small; ROIC remained near 30% even in the weaker FY2025. However, ROE is being diluted by the growing cash pile (cash ≈54% of equity at FY2025), and asset turnover has fallen every year since FY2021 as capacity was added ahead of demand. Inventory discipline improved markedly in FY2025 (DIO 47 days, from 93 in FY2021), offset by slower collections.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityJurisdictionRole

Hyfusin Group Holdings Limited

Cayman Islands

Listed holding company

AVW International Limited

BVI

Parent and ultimate holding company (70.06%)

Fleming Group International Limited

Not stated in filings reviewed

Intermediate holding company; co-guarantor of bank facilities

Fleming International Limited ("Fleming Hong Kong")

Hong Kong

Trading/operating company; HK profits tax payer

Fleming International Vietnam Limited ("Fleming Vietnam")

Vietnam

Manufacturing subsidiary (20% CIT)

Fleming International (Singapore) Pte. Limited

Singapore

Subsidiary (17% CIT); function not described in filings reviewed

Success Glory Worldwide Ltd

Not stated

—

Product category revenue (HKD Mn)

Product category revenue (HKD Mn)FY2020FY2021FY2022FY2023FY2024FY2025

Daily-use candles

98.08146.38110.68111.59123.89112.25

Scented candles

339.72569.97477.28612.18603.58639.25

Decorative candles

17.4318.6910.1527.3133.7550.22

Others incl. diffusers

100.6880.1286.83115.17148.2396.39

Total revenue

555.91815.14684.95866.25909.45898.11

Product category share of revenue (%)

Product category share of revenue (%)FY2020FY2021FY2022FY2023FY2024FY2025

Daily-use candles share (%)

17.618.016.212.913.612.5

Scented candles share (%)

61.169.969.770.766.471.2

Decorative candles share (%)

3.12.31.53.23.75.6

Others incl. diffusers share (%)

18.19.812.713.316.310.7

Product category YoY growth (%)

Product category YoY growth (%)FY2021FY2022FY2023FY2024FY2025

Daily-use candles YoY (%)

49.2-24.40.811.0-9.4

Scented candles YoY (%)

67.8-16.328.3-1.45.9

Decorative candles YoY (%)

7.2-45.7168.923.648.8

Others incl. diffusers YoY (%)

-20.48.432.628.7-35.0

Total revenue YoY (%)

46.6-16.026.55.0-1.2

Product category revenue, half-year (HKD Mn)

Product category revenue, half-year (HKD Mn)1H20251H2026

Scented candles

268.85252.17

Total revenue

369.84341.87

Income statement (HKD Mn)

Income statement (HKD Mn)FY2021FY2022FY2023FY2024FY2025

Revenue

815.14684.95866.25909.45898.11

Cost of sales

545.22477.26530.71557.55614.17

Gross profit

269.92207.69335.54351.90283.94

Other income

1.813.539.1117.7019.17

Other gains and losses net

-3.301.031.7632.33-12.76

Selling and distribution expenses

37.1426.9886.1742.3541.94

Administrative expenses

96.5986.95110.71144.99112.90

Core operating profit (GP less S&D less admin, computed)

136.1993.76138.66164.55129.09

EBIT (PBT plus finance costs, computed)

134.7098.31149.53214.59135.50

Depreciation and amortisation (S&P aggregator)

4.495.235.406.657.93

EBITDA (core op. profit plus aggregator D&A, computed)

140.6898.99144.06171.20137.02

Finance costs

4.918.8114.5711.7710.99

Profit before tax

129.7989.50134.96202.82124.51

Income tax

23.5816.4432.6731.3923.05

Net profit attributable to owners

106.2173.06102.29171.43101.47

Basic EPS (HK cents)

9.666.649.3017.5811.05

Diluted EPS (HK cents)

9.666.649.3017.5811.05

Dividend per share (HK cents)

00000

Margins and growth (%)

Margins and growth (%)FY2021FY2022FY2023FY2024FY2025

Gross margin (%)

33.130.338.738.731.6

Core operating margin (%)

16.713.716.018.114.4

EBITDA margin, aggregator basis (%)

17.314.516.618.815.3

Pre-tax margin (%)

15.913.115.622.313.9

Net margin (%)

13.010.711.818.911.3

Effective tax rate (%)

18.218.424.215.518.5

Revenue growth YoY (%)

46.6-16.026.55.0-1.2

Net profit growth YoY (%)

17.4-31.240.067.6-40.8

Income Statement and Margin Analysis (%)

Half-year metric (HKD Mn unless stated)1H20251H2026

Revenue

369.84341.87

Gross profit

113.7397.63

Gross margin (%)

30.728.6

Administrative expenses

48.5642.34

Selling and distribution expenses

16.6816.45

Other gains and losses net

3.99-12.64

Other income

7.183.84

Finance costs

4.403.30

Net profit attributable

45.1519.59

Basic EPS (HK cents)

4.912.13

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Balance Sheet

Balance sheet at 31 Dec (HKD Mn)FY2021FY2022FY2023FY2024FY2025

Total assets

482.98501.32686.92796.79861.15

Property plant and equipment

60.7268.9190.94142.09172.38

Right-of-use assets

21.5352.1750.4249.4648.03

Inventories

138.98101.36102.50105.4879.69

Trade receivables net

86.4069.0863.12130.97112.25

Bank balances and cash

138.35171.35336.77324.51405.65

Pledged bank deposits (non-current)

19.9022.1419.3518.3018.36

Bank borrowings short-term

46.9123.256.345.075.08

Bank borrowings long-term

15.6726.468.677.663.27

Lease liabilities total

3.364.253.363.703.89

Total debt incl. leases

65.9453.9618.3716.4312.24

Net debt (negative = net cash, excl. pledged deposits)

-72.41-117.39-318.40-308.08-393.41

Total liabilities

152.5398.06181.35149.82112.69

Total equity

330.46403.26505.57646.97748.46

Goodwill and intangibles

00000

Net current assets (working capital)

230.61283.99341.41436.86496.53

Trade payables

45.7118.8839.2645.3046.26

Cash flow (HKD Mn, S&P aggregator)

Cash flow (HKD Mn, S&P aggregator)FY2021FY2022FY2023FY2024FY2025

Operating cash flow

73.3096.61306.98101.12202.08

Capital expenditure

54.096.8434.9264.9861.27

Land-use right purchase

030.48000

Free cash flow (OCF less capex)

19.2189.76272.0636.15140.82

Dividends paid

00000

Share buybacks

00030.000

Net debt repaid (negative = net issuance)

-21.7215.7695.8420.2763.42

Change in working capital

-38.1512.50154.39-45.7159.79

Cash taxes paid

33.5526.1010.1941.4424.21

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2021FY2022FY2023FY2024FY2025

ROE on average equity (%)

38.319.922.529.714.5

ROA on average assets (%)

25.414.817.223.112.2

ROIC, NOPAT over year-end invested capital net of cash (%)

43.226.856.241.029.6

Current ratio (x)

2.695.102.984.125.58

Total debt to equity (%)

20.013.43.62.51.6

Net debt to EBITDA (x, negative = net cash)

-0.51-1.19-2.21-1.80-2.87

Interest coverage, core op. profit over finance costs (x)

27.710.69.514.011.7

Asset turnover, revenue over average assets (x)

1.951.391.461.231.08

Days inventory outstanding (days)

93.077.570.569.147.4

Days sales outstanding (days)

38.736.826.652.645.6

Days payables outstanding (days)

30.614.427.029.727.5

Cash conversion cycle (days)

101.199.970.192.065.5

Revenue by geography (HKD Mn)

Revenue by geography (HKD Mn)FY2020FY2021FY2022FY2023FY2024FY2025

United States

504.20736.27604.97801.38845.57777.79

United Kingdom

44.9268.1772.6960.8459.59109.16

Others

6.7910.707.294.034.3011.16

Total

555.91815.14684.95866.25909.45898.11

Geographic share and growth (%)

Geographic share and growth (%)FY2021FY2022FY2023FY2024FY2025

US share (%)

90.388.392.593.086.6

UK share (%)

8.410.67.06.612.2

Others share (%)

1.31.10.50.51.2

US growth YoY (%)

46.0-17.832.55.5-8.0

UK growth YoY (%)

51.86.6-16.3-2.183.2

Others growth YoY (%)

57.6-31.9-44.76.6159.5

Half-year Geography Details

Half-year geography (HKD Mn)1H2026

United States

318.25

United Kingdom

23.12

Non-current assets by location (HKD Mn)

Non-current assets by location (HKD Mn)FY2021FY2022FY2023FY2024FY2025

Hong Kong

4.095.043.944.384.57

Vietnam

90.01118.90144.11191.67220.25

United States

00007.44

Major customer revenue (HKD Mn)

Major customer revenue (HKD Mn)FY2020FY2021FY2022FY2023FY2024FY2025

Customer A

335.76478.26383.85544.70503.88408.04

Customer A share of revenue (%)

60.458.756.062.955.445.4

Share Price History

DatePrice (HKD)Context

19 Jul 2018

0.295

IPO offer price

Feb 2024 (last close before buyback announcement)

0.219

Pre-announcement close

20 Feb 2024

0.165

Off-market buyback price

~Sep 2025 (trailing 12M range)

0.23 – 0.38

TipRanks 52-week range at time of capture

31 Jul 2026

0.375

StockAnalysis quote

9 Oct 2026

0.375

Latest close available

Valuation Snapshot

MultipleValueBasis

Market capitalisation (HKD Mn)

344.4

918.5M shares

P/E FY2025 (x)

3.4

FY2025 net profit HK$101.5M

P/E TTM Jun-2026 (x)

4.5

TTM net profit HK$75.9M (S&P) [S10]

P/B (x)

0.45

Net assets HK$768.0M at 30 Jun 2026 [S5]

Enterprise value (HKD Mn)

-49.0

Market cap less FY2025 net cash HK$393.4M (cash at Jun 2026 not available)

EV/EBITDA FY2025 (x)

negative

Negative EV

EV/Sales FY2025 (x)

negative

Negative EV

Dividend yield (%)

0

No dividends

Capital Markets

ItemDetailSource

Dividend history

No dividend declared or paid for FY2020–FY2025, nor for 1H2026

[S1][S2][S3][S4][S5]

Buybacks

One off-market buyback: 181.5M shares for HK$30.0M (Apr 2024); general repurchase mandates typically sought at AGMs; no on-market repurchases in FY2025

[S8][S1][S22]

Credit ratings (Moody's/S&P/Fitch)

None — unrated

—

Unutilised banking facilities

HK$112.4M (FY2025)

[S1]

Debt maturity profile at 31 Dec 2025 (HKD Mn)

Within 1 year

1–2 years

Bank borrowings by scheduled repayment

5.082.22

Share Count (M) and Per-Share Data

Multi-year capital markets dataFY2021FY2022FY2023FY2024FY2025

Shares in issue at year-end (M)

1,100.01,100.01,100.0918.5918.5

Net assets per share (HKD)

0.3000.3670.4600.7040.815

Cash per share (HKD)

0.1260.1560.3060.3530.442

Dividends per share (HKD)

00000

Analyst Conclusions

Management guidance

No numerical guidance. Management expects the operating environment to remain challenging and plans proactive marketing, more product-development resources and cost control [S1]. The August 2026 profit warning attributes the 1H2026 decline to fewer new customer orders, lower selling prices and higher production costs [S6]. Consensus growth expectations: none available (no analyst coverage).

Bull case

  1. Valuation below net cash: at HK$0.375 the market capitalisation (≈HK$344M) is below FY2025 net cash (≈HK$393M), implying a negative enterprise value for a business that generated HK$141M of free cash flow in FY2025 [S10][S1].

  2. Trade-diversion optionality: EU anti-dumping duties on Chinese candles (from Aug 2025) [S13] and the US policy tilt against China-made goods could redirect retailer programmes toward Vietnam-based suppliers with existing automated capacity.

  3. Operating leverage on new capacity: two automated factories and a renovated original plant are now complete; any order recovery would fall on a largely fixed-cost base, as demonstrated in FY2023 when gross margin rose 8.4 points [S3].

Bear case

  1. Earnings in sharp decline with no visible floor: net profit fell 40.8% in FY2025 and 56.6% in 1H2026; gross margin is on a three-period downtrend (38.7% → 31.6% → 28.6%) [S1][S5].

  2. Credit and concentration risk compounding: receivable impairments of HK$15.3M (FY2025) and HK$13.4M (1H2026) [S1][S5] coincide with the largest customer cutting purchases by 19% — the downside of 45–63% dependence on one buyer.

  3. Value trap governance: a 70%-controlled company that has paid no dividends since at least FY2020 while accumulating cash may never close the discount to net cash; the only capital return (2024) benefited a single exiting shareholder at a discount [S7][S8].

Catalysts and monitorables (next 12 months)

MonitorableWhy it mattersExpected timing
FY2026 annual resultsConfirms whether 2H2026 stabilises; gross margin trajectory~Mar 2027
Profit alert/warning for FY2026Early read on 2H trends~Feb–Mar 2027
Dividend or buyback decisionKey to closing net-cash discountWith FY2026 results / AGM ~Jun 2027
Customer A revenue and receivable ageingConcentration and credit riskFY2026 annual report
US tariff decisions affecting Vietnamese importsPrimary demand/margin risk per managementOngoing
Bank borrowings and cash at Dec 2026Borrowings rose to HK$30.9M in 1H2026FY2026 results
Nature of new US assetsPossible strategic shift (US presence)FY2026 annual report
Share option grantsIncentive alignmentAny time

Analyst verdict

Hyfusin is a classic small-cap Hong Kong "net-net": an efficient, cash-generative Vietnamese contract manufacturer whose equity is valued below the cash on its balance sheet. The FY2020–FY2024 record was genuinely strong — revenue up 64%, gross margin expanded to 38.7%, debt nearly eliminated, two automated factories built and equity more than doubled without external capital. Returns on operating capital remain high even now, and the balance sheet (cash HK$405.6M versus total liabilities HK$112.7M at FY2025) leaves no solvency question.

However, the investment case has shifted from growth to defence. The FY2025 results and the August 2026 profit warning show a business losing pricing power: lower selling prices and higher production costs have stripped ten points from gross margin in eighteen months, and rising receivable impairments suggest stress among customers or tolerance of slower-paying accounts. With 86–93% of sales going to the US and nearly half to one customer, the group is acutely exposed to US tariff policy and to a single buyer's sourcing decisions — neither of which management can control.

The decisive variable for shareholders is capital allocation. A controlling family holding 70% has chosen to retain all earnings since listing, with the sole buyback structured to remove one holder's block. Unless the board begins returning a meaningful portion of the ≈HK$0.44/share cash (FY2025) through dividends or tender offers, the discount to net cash may persist regardless of operating performance.

Verdict: Fundamentally cheap but operationally deteriorating. Near-term earnings momentum is negative; the re-rating trigger would be either a clear margin stabilisation in FY2026 results or a shift in payout policy. Absent either, the stock is more likely to remain a value trap than to close its discount.


SOURCES REGISTER

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleTenure / appointmentPrior and other rolesEducation

Mr. Wong Wai Chit (Vincent Wong)

Chairman, Executive Director; compliance officer

Founder of listed vehicle (5 Jul 2017); director of Fleming International Ltd (HK) since Jul 1993 per MarketScreener

Director of Fleming Group International Ltd, AVW International Ltd, Fleming International Vietnam Ltd, Success Glory Worldwide Ltd; formerly director of Natural Candle Holdings Ltd, Natural Light Malaysia Ltd, Purple Cloud Zi Yun Design Ltd, Silversmith Workshop Ltd

Not publicly disclosed (in sources reviewed)

Mr. Wong Man Chit (Andrew Wong)

Chief Executive Officer, Executive Director

Founder of listed vehicle (5 Jul 2017); director of Fleming International Ltd (HK) since Jul 1993 per MarketScreener

Director of AVW International, Fleming Group International, Fleming International Vietnam, Success Glory Worldwide; formerly Natural Candle Holdings, Natural Light Malaysia

—

Ms. Wong Wan Yan

Executive Director

———

Mr. Chan Cheong Tat

Independent Non-Executive Director

On board since at least 2022

——

Mr. Ho Chi Wai

Independent Non-Executive Director

Re-elected at 2022 AGM

——

Mr. Chu Kin Wang, Peleus

Independent Non-Executive Director

Re-elected at 2022 AGM

——

“—” = not publicly disclosed.

Governance Overview

Governance attributeStatusSource

Board size

6 (3 executive, 3 INED)

[S1]

Independence

50% independent

computed from [S1]

Chair/CEO separation

Separated in title (Chairman: Wong Wai Chit; CEO: Wong Man Chit), but the two are brothers and joint controlling shareholders acting in concert

[S1]

Gender diversity

1 of 6 directors female (16.7%) since Ms. Wong Wan Yan's appointment; board was all-male at Mar 2024

[S2][S3]

Audit committee

Exists; reviewed FY2025 accounts

[S1]

CG Code compliance

Board states compliance with all applicable code provisions in FY2025

[S1]

Dealing code

GEM Rules 5.48–5.67 Required Standard of Dealings adopted; no non-compliance noted

[S1]

Board & Management Changes

DateChangeContext

Between Mar 2024 and Mar 2025

Ms. Wong Wan Yan joins as executive director

Expands executive board from 2 to 3

10 Jun 2022 AGM

Re-election of Wong Wai Chit, Ho Chi Wai, Chu Kin Wang Peleus

Routine rotation

Major Shareholders

ShareholderSharesStake (%)

AVW International Limited (50% Wong Man Chit, 50% Wong Wai Chit)

643,500,00070.06

Public shareholders

275,000,00029.94

Total

918,500,000100.00

Competitive Landscape

Key Competitors

CompetitorTypeRelevance to HyfusinRevenue (latest verified)Source / status

Kwung's Aroma Holdings (1925.HK, formerly Kwung's Holdings)

China-based ODM/OEM of candles, home fragrance and accessories; HK Main Board

Closest listed peer; export-focused candle maker

RMB882.1M FY2025 (−11.9%); RMB1,001.2M FY2024

[S13]

Qingdao Kingking Applied Chemistry (002094.SZ)

Chinese candle manufacturer/exporter (historically)

China-based candle exporter

——

Bolsius

Dutch candle manufacturer (private)

European candle supply; UK exposure

——

Empire Candle Co.

US candle manufacturer (private)

US private-label and licensed candles

——

Yankee Candle (Newell Brands brand)

US brand owner with own manufacturing

Competes for shelf space; may also outsource

——

Bath & Body Works (vendor base)

Specialty retailer with dedicated candle supply chain

Competes for US consumer spend; potential customer

——

Other Chinese candle exporters

Contract manufacturers

Now facing EU anti-dumping duties on Chinese candles (since Aug 2025) per Kwung's

—

[S13]

Vietnamese and other Southeast Asian contract manufacturers

Contract manufacturers

Compete on similar cost base and tariff position

——

Indian candle exporters

Contract manufacturers

Alternative low-cost source

——

Retailers' in-house / direct-sourcing programmes

Customers' alternatives

Bargaining power over price

—

Inferred

“—” = not publicly disclosed.

Peer Comparison FY2025

MetricHyfusin FY2024Hyfusin FY2025Kwung's FY2024Kwung's FY2025

Revenue (local currency M)

909.45898.111,001.22882.12

Revenue growth (%)

5.0-1.224.1-11.9

Gross margin (%)

38.731.622.4—

Net profit (local currency M)

171.43101.47118.66—

Net margin (%)

18.911.311.9—

Recent Developments

All identified items are listed, followed by key earlier context.

Company Snapshot

$115.3M

Revenue

1,240

Employees

1993

Founded

Windward, Cayman Islands

Headquarters

SWOT Analysis

Strengths

  • Net cash balance sheet: cash HK$405.6M versus total debt (incl. leases) HK$12.2M at 31 Dec 2025; gearing 1.6% [S1].
  • High returns on operating capital: ROIC ≈30% in FY2025 and 41% in FY2024 (computed) despite a downturn.
  • Superior gross margin versus listed peer: 38.7% (FY2024) vs Kwung's 22.4% [S2][S13].
  • Automated, modern capacity: two new factories (2022, 2024) plus renovated original plant; management credits automation for lower overhead [S3][S2][S1].
  • Deep customer embedding: major-customer partner awards in 2020 and 2021 for owned-brand development [S4].
  • Improved working-capital discipline: DIO cut from 93 days (FY2021) to 47 days (FY2025) (computed).

Weaknesses

  • Customer concentration: Customer A was 45.4% of FY2025 revenue and 62.9% of FY2023 [S1][S3].
  • Geographic concentration: US 86.6% of FY2025 and 93.1% of 1H2026 revenue [S1][S5].
  • Margin volatility and recent compression: gross margin 38.7% (FY2024) → 31.6% (FY2025) → 28.6% (1H2026) [S1][S5].
  • Deteriorating receivables: credit-loss allowance rose from HK$2.4M to HK$17.7M in FY2025; further HK$13.4M impairment in 1H2026 [S1][S5].
  • Product-quality incident: ≈7.1M glass-jar candles recalled; US$3.0M settlement [S9][S2].
  • Limited disclosure: single segment, no R&D, capacity or utilisation data; no guidance [S1].

Opportunities

  • Trade diversion away from China: EU anti-dumping duties on Chinese candles since Aug 2025 [S13] could favour Vietnam-based supply, especially for European/UK customers.
  • UK diversification: UK revenue +83% in FY2025 to HK$109.2M [S1].
  • Category expansion: decorative candles grew from HK$10.2M (FY2022) to HK$50.2M (FY2025) [S3][S1].
  • Capital return: market cap (≈HK$344M) below FY2025 net cash (≈HK$393M); the 2024 buyback at HK$0.165 showed willingness to retire stock [S7][S10].
  • US presence: new US non-current assets in FY2025 may support closer customer servicing [S1].
  • Operating leverage from new capacity if order volumes recover, given fixed-cost automated plants.

Threats

  • US tariff policy: management names unresolved US tariff policy as the main operating pressure [S1].
  • Retailer pricing power: lower selling prices drove FY2025 and 1H2026 margin declines [S1][S5].
  • Order softness: 1H2026 profit warning cites fewer new orders [S6].
  • Raw-material inflation: FY2021 wax cost +≈37% cut gross margin by 4 points [S4].
  • Regulatory/product-safety exposure: CPSC alerts can trigger recalls and claims [S9].
  • Competitive capacity from other low-cost countries responding to the same trade-diversion opportunity (inferred; not quantified).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
outside 18-month window*Earlier context** 18 Dec 2023 recall announcement [S9]; 20 Feb 2024 buy-back agreement [S7]; 24 Apr 2024 buy-back completion [S8]; 7 Jun 2024 share option scheme [S2]; 9 Aug 2024 positive profit alert [S19]; Aug–Sep 2024 Vietnam property disposals [S2]; Oct 2024 renovation contract [S2]; 14 Mar 2025 positive profit alert for FY2024 [S19]; 21 Mar 2025 FY2024 record results [S2].

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

8 charts
Income Statement: Revenue & Gross Profit: Revenue rose from HKD 815.1 Mn in FY2021 to HKD 898.1 Mn in FY2025.
Hyfusin Group Holdings Limited — Income Statement: Revenue & Gross Profit
Series (HKD Mn)FY2021FY2022FY2023FY2024FY2025
Revenue815.1685866.3909.5898.1
Cost of sales545.2477.3530.7557.6614.2
Gross profit269.9207.7335.5351.9283.9

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.